These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 9133118)

  • 21. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta blocker treatment in heart failure.
    Carson PE
    Prog Cardiovasc Dis; 1999; 41(4):301-21. PubMed ID: 10362350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beta blockers in therapy of chronic heart failure].
    Hoffman J; Grimm W; Maisch B
    Herz; 2002 Mar; 27(2):150-65. PubMed ID: 12025460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-blocker therapy in heart failure in the elderly.
    Fu M
    Int J Cardiol; 2008 Apr; 125(2):149-53. PubMed ID: 18023898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN; Sharpe N
    Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
    Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of beta-adrenergic blocking agents in congestive heart failure.
    Krukemyer JJ
    Clin Pharm; 1990 Nov; 9(11):853-63. PubMed ID: 1980240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heart insufficiency treated with beta-blocking agents. Comparison of responders and non-responders].
    Mattioli AV; Parato VM; Vivoli D; Bergomi M
    Cardiologia; 1992 May; 37(5):337-43. PubMed ID: 1358443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching beta-blocker therapy in chronic heart failure.
    Tomcsányi J; Wettstein A; Toldy-Schedel E; Somlói M
    Int J Cardiol; 2008 Nov; 130(3):497-9. PubMed ID: 17707095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
    Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
    Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of global region on outcomes in heart failure β-blocker trials.
    O'Connor CM; Fiuzat M; Swedberg K; Caron M; Koch B; Carson PE; Gattis-Stough W; Davis GW; Bristow MR
    J Am Coll Cardiol; 2011 Aug; 58(9):915-22. PubMed ID: 21851879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenergic blockers for chronic heart failure.
    Javed U; Deedwania PC
    Cardiol Rev; 2009; 17(6):287-92. PubMed ID: 19829179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression and beta-blockade in heart failure.
    Lee HR; O'Connell JB; Mason JW
    Cardiol Clin; 1989 Feb; 7(1):171-81. PubMed ID: 2565162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-blockers and heart failure.
    Cruickshank JM
    Indian Heart J; 2010; 62(2):101-10. PubMed ID: 21180298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.